NL8100037A - Farmaceutische preparaten. - Google Patents

Farmaceutische preparaten. Download PDF

Info

Publication number
NL8100037A
NL8100037A NL8100037A NL8100037A NL8100037A NL 8100037 A NL8100037 A NL 8100037A NL 8100037 A NL8100037 A NL 8100037A NL 8100037 A NL8100037 A NL 8100037A NL 8100037 A NL8100037 A NL 8100037A
Authority
NL
Netherlands
Prior art keywords
release
amount
sustained
agent
per tablet
Prior art date
Application number
NL8100037A
Other languages
English (en)
Dutch (nl)
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of NL8100037A publication Critical patent/NL8100037A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8100037A 1980-01-11 1981-01-07 Farmaceutische preparaten. NL8100037A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US11143080 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments
US19445380 1980-10-17

Publications (1)

Publication Number Publication Date
NL8100037A true NL8100037A (nl) 1981-08-03

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8100037A NL8100037A (nl) 1980-01-11 1981-01-07 Farmaceutische preparaten.

Country Status (22)

Country Link
JP (1) JPS56103110A (fi)
AT (1) AT374681B (fi)
AU (1) AU542824B2 (fi)
BE (1) BE886998A (fi)
CA (1) CA1140466A (fi)
CH (1) CH646604A5 (fi)
DE (1) DE3100191A1 (fi)
DK (1) DK6181A (fi)
ES (2) ES498369A0 (fi)
FI (1) FI76927C (fi)
FR (1) FR2473308B1 (fi)
GB (1) GB2067072B (fi)
GR (1) GR73843B (fi)
IE (1) IE50806B1 (fi)
IN (1) IN151913B (fi)
IT (1) IT1221041B (fi)
LU (1) LU83052A1 (fi)
NL (1) NL8100037A (fi)
NO (1) NO156153C (fi)
NZ (1) NZ195933A (fi)
SE (1) SE447450B (fi)
ZA (1) ZA81136B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
EP0230647B1 (en) * 1985-12-27 1993-03-31 Sumitomo Pharmaceuticals Company, Limited Method for producing a sustained release formulation
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
CA1316110C (en) * 1987-02-27 1993-04-13 Peter Lloyd Oren Sustained release matrix formulations
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5855915A (en) * 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
NL265428A (fi) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
NO156153C (no) 1987-08-05
AU6597681A (en) 1981-07-16
NZ195933A (en) 1982-11-23
JPS56103110A (en) 1981-08-18
ATA5481A (de) 1983-10-15
IE810036L (en) 1981-07-11
DE3100191C2 (fi) 1988-09-01
SE8100104L (sv) 1981-07-12
FI76927C (fi) 1989-01-10
ES8205353A1 (es) 1982-06-01
FI76927B (fi) 1988-09-30
AU542824B2 (en) 1985-03-14
DK6181A (da) 1981-07-12
BE886998A (fr) 1981-07-08
ES8301629A1 (es) 1982-12-16
FR2473308A1 (fr) 1981-07-17
LU83052A1 (fr) 1982-09-10
IN151913B (fi) 1983-09-03
GB2067072A (en) 1981-07-22
DE3100191A1 (de) 1981-12-10
NO156153B (no) 1987-04-27
AT374681B (de) 1984-05-25
ZA81136B (en) 1982-01-27
CH646604A5 (fr) 1984-12-14
IE50806B1 (en) 1986-07-23
IT8147537A0 (it) 1981-01-09
IT1221041B (it) 1990-06-21
NO810062L (no) 1981-07-13
GB2067072B (en) 1983-08-10
FI810056L (fi) 1981-07-12
ES509179A0 (es) 1982-12-16
SE447450B (sv) 1986-11-17
GR73843B (fi) 1984-05-07
FR2473308B1 (fr) 1985-07-19
CA1140466A (en) 1983-02-01
ES498369A0 (es) 1982-06-01

Similar Documents

Publication Publication Date Title
NL8100037A (nl) Farmaceutische preparaten.
US4913906A (en) Novel controlled release dosage form of valproic acid
US3965256A (en) Slow release pharmaceutical compositions
US4235870A (en) Slow release pharmaceutical compositions
DK175627B1 (da) Farmaceutisk præparat til oral indgift med reguleret afgivelse og forlænget virkning
JP2519296B2 (ja) イブプロフェン除放性錠剤及びその製造方法
JPS63107917A (ja) イブプロフエン徐放性製剤およびその製造方法
JP5105685B2 (ja) 甲状腺ホルモンの製薬化
EA018082B1 (ru) Препаративная форма для лечения гиперактивности при дефиците внимания, фармацевтическая композиция на ее основе и способ лечения гиперактивности при дефиците внимания
PT89467B (pt) Processo para a preparacao de novas formulacoes galenicas de libertacao programada
PT86212B (pt) Processo para a preparacao de uma formulacao galenica
EP0231826A2 (en) Theophylline sustained release tablet
KR20050119106A (ko) 주의부족 과활성장애(ａｄｈｄ) 치료를 위한 에난티오머성암페타민 조성물
Chandira et al. Formulation and evaluation of extended release tablets containing metformin HCl
BRPI0619934A2 (pt) composição farmacêutica de liberação prolongada, processo para a preparação de uma composição, uso de uma composição, e, uso de uma composição
JPS6087216A (ja) 一定放出性固体投薬形インドメタシン組成物および関節炎その他の炎症性状態の治療法
US20090149543A1 (en) Solid pharmaceutical compositions comprising lumiracoxib
EP2087893A1 (en) Compositions comprising alprazolam for treating primary insomnia and insomnia associated with anxiety states and processes for preparing them
JPS6087217A (ja) 一定放出速度の固体調剤テオフイリン配合物
JPH0667828B2 (ja) バルプロ酸ナトリウムの持続性顆粒製剤
CN116966157B (zh) 一种茶碱缓释片及其制备方法
EP0206240A2 (en) Solid pharmaceutical composition for oral use
RU2177318C1 (ru) Фармацевтическая композиция с антидиабетическим действием и способ ее получения
JPH11322584A (ja) ベザフィブラート徐放性製剤
JP2005517720A (ja) レボチロキシン組成物及び方法

Legal Events

Date Code Title Description
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BOOTS COMPANY PLC. THE -

A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed